STATCenter·
STAT+: Definium’s LSD therapy eased anxiety in second large trial
The first wave of biotechs is nearing regulatory approval for psychedelic therapies, a class of treatments that appear to exert rapid benefits.
Read at STAT →
Health · 1 sources covering this
STAT+: Definium’s LSD therapy eased anxiety in second large trial
The first wave of biotechs is nearing regulatory approval for psychedelic therapies, a class of treatments that appear to exert rapid benefits.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/cf3029d03ca899eb52e9e40a8518b82b931c1bdd" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Definium’s LSD therapy eased anxiety in second large trial"></iframe>
